Short Interest in Silo Pharma, Inc. (NASDAQ:SILO) Increases By 38.7%

Silo Pharma, Inc. (NASDAQ:SILO) was the target of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 181,200 shares, an increase of 38.7% from the February 28th total of 130,600 shares. Based on an average trading volume of 2,900,000 shares, the short-interest ratio is currently 0.1 days. Currently, 4.2% of the company’s stock are short sold.

Silo Pharma Price Performance

Shares of SILO stock traded down $0.01 during trading on Tuesday, reaching $1.16. The company had a trading volume of 15,944 shares, compared to its average volume of 3,092,205. The company has a market capitalization of $5.20 million, a PE ratio of -0.95 and a beta of 0.01. The firm’s 50 day simple moving average is $1.49 and its two-hundred day simple moving average is $1.24. Silo Pharma has a one year low of $0.77 and a one year high of $4.50.

Silo Pharma (NASDAQ:SILO) last released its quarterly earnings results on Friday, March 28th. The company reported ($0.41) EPS for the quarter. The firm had revenue of $0.02 million during the quarter. Silo Pharma had a negative net margin of 5,255.05% and a negative return on equity of 61.38%.

About Silo Pharma

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.